_frequent-us-fda-observations-2019-amp-how-to-respond-to-fda-preview-1.jpg "Frequent US FDA Observations 2019& How to Respond to FDA from fda observations in 2019 Video Screenshot Preview 1")
Gallery_frequent-us-fda-observations-2019-amp-how-to-respond-to-fda-preview-3.jpg "Frequent US FDA Observations 2019& How to Respond to FDA from fda observations in 2019 Video Screenshot Preview 3")
Gallery_frequent-us-fda-observations-2019-amp-how-to-respond-to-fda-preview-hqdefault.jpg "Frequent US FDA Observations 2019& How to Respond to FDA from fda observations in 2019 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 hours 30 minutes 1 second
👁 View: 1.1K times
Play Audio:👁 View: 1.1K times
Description:
Pharma Best Practices Webinars
Pharma Best Practices Webinars
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_fda-483-observations-and-warning-letter-citations-2019-2020-fda-drug-gmp-john-lee-video-2-of-9.webp "This 2nd video (out of 9 in total) focuses on FDA Form 483 observations and Warning Letters, overall statistics for 2019 (and partly 2020) for Drug GMP.nnHere you will find, a 9% increase in number of FDA-483's in 2019 compared to 2018. In absolute numbers, 779 FDA-483’s in 2019 as compared to 716 in 2018.nnTop 3 issues in FDA-483’s are in 2019 (still) violation of CFR,n• 211.22(d), Quality Assurance Oversightn• 211.192, Investigationsn• 211.160(b), Laboratory Controlnn98 Warning Lette")
FDA-483 observations and Warning Letter citations 2019 – 2020. FDA Drug GMP (John Lee, Video 2 of 9)
⏲ 4 min 50 sec ✓ 29-Oct-2020
_fda-483-observations-and-warning-letter-citations-2019-2020-fda-drug-gmp-john-lee-video-2-of-9.webp "Genau u0026 More A/S More")
FDA-483 observations and Warning Letter citations 2019 – 2020. FDA Drug GMP (John Lee, Video 2 of 9)
⏲ 7 minutes 31 seconds 👁 132
_growing-number-of-americans-are-trying-weight-loss-drugs.webp "Growing , Number of Americans Are Trying , Weight-Loss Drugs.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>According to the poll, three percent <br/>of those users are specifically <br/>using the drug for weight loss.<br/>The poll found that people between the ages <br/>of 40 and 64 are the most likely to try Ozempic <br/>or competitors, like Wegovy or Saxenda. .<br/>In 2017, the U.S. Food and Drug <br/>Administration (FDA) approved Ozempic <br/>to treat cardiovascular disease and diabetes. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>The popularity of the drug has resulted <br/>in various makers reporting shortages. .<br/>The drug companies didn't <br/>anticipate how popular <br/>these drugs would become, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'.<br/>Since they are being used <br/>for many issues, like diabetes, <br/>heart failure, obesity, <br/>this exacerbates the <br/>shortages significantly, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'")
_most-common-issues-with-cdisc-send-data-in-fda-toxicology-review-sep-12-2019.webp "U.S. Food and Drug Administration")
⏲ 54 minutes 21 seconds 👁 2.8K
_2019-ccts-fda-conference-cder-bimo-compliance-and-enforcement.webp "OSU Center for Clinical and Translational Science")
_fda-483-observations-and-warning-letter-citations-2019-2020-fda-drug-gmp-john-lee-video-2-of-9.jpg)
_fda-483-observations-and-warning-letter-citations-2019-2020-fda-drug-gmp-john-lee-video-2-of-9.jpg)
_growing-number-of-americans-are-trying-weight-loss-drugs.jpg)
_most-common-issues-with-cdisc-send-data-in-fda-toxicology-review-sep-12-2019.jpg)
_2019-ccts-fda-conference-cder-bimo-compliance-and-enforcement.jpg)
![[+]](/images/menu.gif){kind=small}